Senores Pharmaceuticals IPO Vs Ventive Hospitality IPO: Which issue will list with higher gains?

As the calendar year 2024 draws to a close, the primary market continues its stellar run with a flurry of activity. Amongst the three mainboard IPOs that are going to list today (December 30), two issues are in the spotlight – Senores Pharmaceuticals and Ventive Hospitality with much speculation on which issue might deliver better gains.

Although both companies come from different sectors and carry their own market dynamics, let’s take a look at the key details of the issue and their potential listing performance.

Grey Market Premium: What Does It Indicate?

The grey market premium (GMP) is often seen as an early indicator of investor sentiment.

Also Read Upcoming IPOs this week: Indo Farm Equipment IPO and 4 SMEs set to open for subscription – Here are all the details  Upcoming IPOs this week: Unimech Aerospace – a key mainboard and 2 SME IPOs to launch this week Vishal Mega Mart sees a strong debut; lists at 33% premium to issue price on NSE Ventive Hospitality Stock debuts at 12% premium; Details on how the stock is performing after listing?

As per the recent trend, prior to some hours before the official listing of the company, the shares of Senores Pharmaceuticals has been trading at a GMP of Rs 284, suggesting a possible listing price of Rs 675 per share, a 72.63 per cent higher than its upper price band of Rs 391. Furthermore, it is also important to note that over the past two weeks, its GMP has consistently remained strong.

Also Read: Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Check listing price, GMP, allotment status, and other details

On the other side, Ventive Hospitality’s GMP is relatively subdued at Rs 70. This translates to an estimated listing price of Rs 713 per share, which is 10.89 per cent higher than its IPO price of Rs 643.

However, it is important to note that GMP is just an indicator of market sentiment and not a guarantee of the actual listing price or future performance of the stock.

Lot Size

Now coming to the lot size, for retail investors, the minimum investment in the Senores Pharmaceuticals IPO starts at Rs 14,858 for one lot of 38 shares. Small High Net Worth Individuals (sNII) must apply for at least 14 lots,

 » Read More

Related Articles

Trump names cryptos for US Strategic Reserve; XRP, SOL, ADA see major gains

US President Donald Trump on Sunday unveiled plans for a US Crypto Strategic Reserve, featuring three major cryptocurrencies—XRP (Ripple), SOL (Solana), and ADA (Cardano). The announcement sparked a market rally, with these digital assets surging between 10% and 35%. Crypto policy Trump’s move follows his January executive order directing the Presidential Working Group to establish

Samir Arora slams Govt against capital gains tax on FIIs, says ‘huge mistake’

Samir Arora, founder and CIO of Helios Capital, has strongly criticised the Indian government’s decision to raise capital gains tax, particularly for foreign institutional investors (FIIs), calling it a “huge mistake.” Speaking at the Business Standard Manthan Summit 2025, Arora argued that this policy is damaging investor confidence and contributing to massive sell-offs in Indian

Non-food items post steady rise in FMCG pie despite inflation

Products such as skin creams, floor cleaners and washing powders are finding a little more space in the shopping baskets these days as a combination of aggressive offers, innovative formats and new launches are pushing consumers to stock up these items. The food basket, in contrast, is seeing lower volume growth as inflation concerns prompt

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump names cryptos for US Strategic Reserve; XRP, SOL, ADA see major gains

US President Donald Trump on Sunday unveiled plans for a US Crypto Strategic Reserve, featuring three major cryptocurrencies—XRP (Ripple), SOL (Solana), and ADA (Cardano). The announcement sparked a market rally, with these digital assets surging between 10% and 35%. Crypto policy Trump’s move follows his January executive order directing the Presidential Working Group to establish

Samir Arora slams Govt against capital gains tax on FIIs, says ‘huge mistake’

Samir Arora, founder and CIO of Helios Capital, has strongly criticised the Indian government’s decision to raise capital gains tax, particularly for foreign institutional investors (FIIs), calling it a “huge mistake.” Speaking at the Business Standard Manthan Summit 2025, Arora argued that this policy is damaging investor confidence and contributing to massive sell-offs in Indian

Non-food items post steady rise in FMCG pie despite inflation

Products such as skin creams, floor cleaners and washing powders are finding a little more space in the shopping baskets these days as a combination of aggressive offers, innovative formats and new launches are pushing consumers to stock up these items. The food basket, in contrast, is seeing lower volume growth as inflation concerns prompt

Q-comm drives revival of roll-up commerce startups

After a period of turbulence and skepticism, roll-up commerce startups are making a steady comeback, thanks to the rapid expansion of quick commerce as a critical sales channel. These startups, which acquire and scale small but promising brands through improved operations, marketing, and technology, are now seeing renewed investor confidence and revenue growth, even as

‘Very opportunistic time’ to invest in equities: Morgan Stanley India MD

India’s equity market is in a bright spot despite ongoing corrections, and this may well be an ‘opportunistic time’ to invest in stocks, Morgan Stanley India managing director Ridham Desai said on Sunday. Speaking at event, Desai said shifting consumption patterns, rising energy usage and increasing consumer borrowing will drive India’s growth in coming decades